H-G. Kopp

858 total citations
18 papers, 556 citations indexed

About

H-G. Kopp is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, H-G. Kopp has authored 18 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 4 papers in Oncology. Recurrent topics in H-G. Kopp's work include Gastric Cancer Management and Outcomes (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Bariatric Surgery and Outcomes (3 papers). H-G. Kopp is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Bariatric Surgery and Outcomes (3 papers). H-G. Kopp collaborates with scholars based in Germany, Austria and United States. H-G. Kopp's co-authors include Andreas Festa, Guntram Schernthaner, R. Roka, E Minar, Christoph Kopp, Stefan Kriwanek, Katarzyna Krzyżanowska, G. Schernthaner, E. J. Menzel and Peter Quehenberger and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Diabetologia and Annals of Oncology.

In The Last Decade

H-G. Kopp

15 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H-G. Kopp Germany	6	211	187	142	138	86	18	556
Amy Nolan Ireland	4	258 1.2×	183 1.0×	77 0.5×	120 0.9×	86 1.0×	9	513
Guenter Hoefle Austria	14	215 1.0×	109 0.6×	118 0.8×	215 1.6×	246 2.9×	17	652
Maria Rosaria Manigrasso Italy	10	212 1.0×	149 0.8×	46 0.3×	131 0.9×	78 0.9×	15	467
Mirosława Urban Poland	14	148 0.7×	95 0.5×	114 0.8×	191 1.4×	209 2.4×	74	796
Niina Siitonen Finland	11	188 0.9×	181 1.0×	53 0.4×	170 1.2×	82 1.0×	13	631
Zbigniew Bartoszewicz Poland	15	77 0.4×	173 0.9×	123 0.9×	69 0.5×	110 1.3×	46	615
Shigehiko Fujiwara Japan	8	163 0.8×	163 0.9×	68 0.5×	202 1.5×	240 2.8×	8	582
Brian Carmine United States	15	179 0.8×	299 1.6×	245 1.7×	187 1.4×	51 0.6×	29	617
Carsten T. Herz Austria	14	115 0.5×	257 1.4×	115 0.8×	104 0.8×	39 0.5×	35	508
Melissa R. Meyers United States	6	212 1.0×	192 1.0×	48 0.3×	172 1.2×	41 0.5×	9	433

Countries citing papers authored by H-G. Kopp

Since Specialization

Citations

This map shows the geographic impact of H-G. Kopp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H-G. Kopp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H-G. Kopp more than expected).

Fields of papers citing papers by H-G. Kopp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H-G. Kopp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H-G. Kopp. The network helps show where H-G. Kopp may publish in the future.

Co-authorship network of co-authors of H-G. Kopp

This figure shows the co-authorship network connecting the top 25 collaborators of H-G. Kopp. A scholar is included among the top collaborators of H-G. Kopp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H-G. Kopp. H-G. Kopp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Saalfeld, Felix Carl, Michael Rost, Charles Elias Assmann, et al.. (2024). 1300P Treatment sequences in BRAF-V600-mutant non-small cell lung cancer: First-line targeted therapy versus first-line (chemo-) immunotherapy. Annals of Oncology. 35. S827–S828.

Stratmann, Jan, Nikolaj Frost, Petros Christopoulos, et al.. (2023). 1405P Sotorasib in KRAS G12C-mutated NSCLC: A multicenter real-world experience from the expanded access program in Germany. Annals of Oncology. 34. S804–S804. 1 indexed citations

Heilig, Christoph E., Susan Richter, Jens T. Siveke, et al.. (2022). 487P Randomized phase II study of trabectedin/olaparib compared to physician’s choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies. Annals of Oncology. 33. S762–S763.

Shah, Rajiv, Laura V. Klotz, Manuel Feißt, et al.. (2020). 1912TiP NICITA: Nivolumab with chemotherapy in pleural mesothelioma after surgery. Annals of Oncology. 31. S1083–S1083. 1 indexed citations

Al-Batran, S-E., Ralf‐Dieter Hofheinz, Harald Schmalenberg, et al.. (2020). 1424MO Perioperative FLOT plus ramucirumab versus FLOT alone for resectable esophagogastric adenocarcinoma– Updated results and subgroup analyses of the randomized phase II/III trial RAMSES/FLOT7 of the German AIO and Italian GOIM. Annals of Oncology. 31. S901–S901. 5 indexed citations

Casali, Paolo G., Axel Le Cesne, Andrés Poveda, et al.. (2017). Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: Final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial. Annals of Oncology. 28. v645–v645.

Pauligk, Claudia, Sylvie Lorenzen, Thorsten Oliver Goetze, et al.. (2017). A randomized, double-blind, multi-center phase III study evaluating paclitaxel with and without RAD001 in patients with gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC). Annals of Oncology. 28. v228–v228. 2 indexed citations

Al-Batran, S-E., Claudia Pauligk, Nils Homann, et al.. (2017). Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO). Annals of Oncology. 28. v616–v616. 16 indexed citations

Pawel, Joachim von, Stefanie Kraff, Wilfried Eberhardt, et al.. (2016). Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin in advanced Non-Small Cell Lung Cancer (NSCLC) patient. Pneumologie. 70(S 01). 4 indexed citations

10.

Sperker, Christoph, et al.. (2012). Technique and results of single-step laparoscopic sleeve resection*. European surgery. Supplement/European surgery. 44(1). 23–27. 1 indexed citations

11.

Kopp, H-G., et al.. (2010). Thrombin generation in morbid obesity: significant reduction after weight loss. Journal of Thrombosis and Haemostasis. 8(4). 759–765. 90 indexed citations

12.

Kopp, H-G., P. Hopmeier, & Guntram Schernthaner. (2009). Concentrations of circulating P-Selectin are increased in patients with newly diagnosed insulin-dependent diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes. 106(1). 41–44. 3 indexed citations

13.

Kopp, H-G., et al.. (2006). Grundsätze der ärztlichen Beurteilung der Zumutbarkeit und Arbeitsfähigkeit. Teil 1. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 6(18). 1 indexed citations

14.

Kopp, H-G., et al.. (2006). Grundsätze der ärztlichen Beurteilung der Zumutbarkeit und Arbeitsfähigkeit. Teil 2. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 6(19). 2 indexed citations

15.

Kopp, H-G., Christoph Kopp, Andreas Festa, et al.. (2003). Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients. Arteriosclerosis Thrombosis and Vascular Biology. 23(6). 1042–1047. 331 indexed citations

16.

Kopp, H-G., Andreas Festa, Walter Krugluger, & G. Schernthaner. (2001). Low Levels of Sex-Hormone-Binding Globulin predict insulin requirement in patients with gestational diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes. 109(7). 365–369. 30 indexed citations

17.

Festa, Andreas, H-G. Kopp, Guntram Schernthaner, & E. J. Menzel. (1998). Autoantibodies to oxidised low density lipoproteins in IDDM are inversely related to metabolic control and microvascular complications. Diabetologia. 41(3). 350–356. 67 indexed citations

18.

Kopp, H-G., Anna Festa, P. Hopmeier, & G. Schernthaner. (1996). [Evaluation of a new method for determining glycated hemoglobin with monoclonal antibodies (DCA 2000)].. PubMed. 108(1). 16–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact